Aliko Scientific U.S. Unit to Receive $2M in Dispute Settlement

Aliko Scientific (ALIKO.PA) said Monday its wholly owned U.S. subsidiary reached a settlement resolving an existing dispute, with the unit set to receive $2 million. The French life sciences group, focused on integrated oncology diagnostics, disclosed the agreement on Sept. 21, 2026. It did not specify the counterparty or the nature of the dispute in its announcement.